All News

2021

March

Media Release / Mar 05, 2021

Novartis announces change to the Executive Committee

Read More
Illustration of the coronavirus created at the Centers for Disease Control and Prevention (CDC)
Featured News / Mar 04, 2021

Coronavirus (COVID-19) news feed

Read More
Media Release / Mar 04, 2021

Novartis signs initial agreement with CureVac to manufacture COVID-19 vaccine candidate

Read More
Media Release / Mar 02, 2021

Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting

Read More
RNA strand
Story / Mar 02, 2021

Take a visual tour of medicines that target RNA

A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.

Read More
Illustration of planet earth
Featured News / Mar 01, 2021

On a mission to transform planetary health

The first One Young World – Novartis Caucus took place virtually on February 11, 2021.

Read More

February

Media Release / Feb 26, 2021

Novartis strengthens Oncology pipeline with successful closing of tislelizumab in-licensing

Read More
Media Release / Feb 26, 2021

Novartis Cosentyx® gains EU label update for first-of-its-kind MAXIMISE data in axial manifestations of psoriatic arthritis

Read More
Media Release / Feb 17, 2021

Novartis and the Bill & Melinda Gates Foundation collaborate to discover and develop an accessible in vivo gene therapy for sickle cell disease

Read More
Media Release / Feb 16, 2021

Novartis Entresto® granted expanded indication in chronic heart failure by FDA

Read More

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.

Learn More